Abnormal Fibrinogens

 

^* This paper was presented at the Plenary Session : Molecular biology and pathophysiology of fibrinogen. Ill Congress of the International Society on Thrombosis and Haemostasis,, Washington D. C., 1972.

• References

• 1 Aiach M, Roge J, Busy M. F, Durand H, Gueroult N, Chanrion Ch, Leclec M, et Justin-Besançon L. 1973; Dysfibrinogénémies acquises et affections hépatiques. A propos de 30 observations. Semaine des Hôpitaux de Paris 49: 183.
• 2 Andre E. 1971 Les dysfibrinogénémies. Etude du fibrinogène Nancy. Thèse (Nancy).
• 3 Beck E. A. 1964; Abnormal fibrinogen (Fibrinogen “Baltimore”) as a cause of a familial hemorrhagic disorder. Blood 24: 853.
• 4 Beck E. A. 1968. Congenital variants of human fibrinogen. In: Laki K. (ed.) Fibrinogen . Dekker M., Inc; New York: 269.
• 5 Beck E. A. 1970; Diagnosis of structural abnormalities of human fibrinogen. Thrombosis et Diathesis Haemorrhagica suppl. 39 323.
• 6 Beck E. A, Charache P, Jackson D. P. 1965; A new inherited coagulation disorder caused by an abnormal fibrinogen (Fibrinogen “Baltimore”). Nature, London 208: 143.
• 7 Beck E. A, Mosesson M. W, Charache P, Jackson D. P. 1966; Hämorrhagische Diathese mit dominantem Erbgang, verursacht durch ein anomales Fibrinogen (Fibrinogen “Baltimore”). Schweizerische Medizinische Wochenschrift 96: 1196.
• 8 Beck E. A, Shainoff J. R, Vogel A, Jackson D. P. 1971; Functional evaluation of an inherited abnormal fibrinogen: Fibrinogen “Baltimore”. The Journal of Clinical Investigation 50: 1874.
• 9 Blombäck B. 1970; In Discussion. Thrombosis et Diathesis Haemorrhagica suppl. 39 337.
• 10 Blombäck B. 1971; Subunit structure of fibrinogen. Scandinavian Journal of Haematology suppl. 13 71.
• 11 Blombäck M, Blombäck B. 1970. Fibrinogen “Detroit”: a molecular defect in the N terminal disulphide knot. In: Brinkhous K. M. (ed.) Hemophilia and New Hemorrhagic States . University of North Carolina Press; Chapel Hill: 242.
• 12 Blombäck M, Blombäck B, Mammen E. F, Prasad A. S. 1968. Fibrinogen “Detroit” a molecular defect in the N-terminal disulphide knot of human fibrinogen. Nature. London: 218 134.
• 13 Egeberg O. 1967; Inherited abnormality causing thrombophilia. Thrombosis et Diathesis Haemorrhagica 17: 176.
• 14 Von Felten A. F, Duckert F, Frick P. 1965; Gerinnungsstörung ohne hämorrhagische Diathese infolge verzögerter Aggregation der Fibrinmoleküle. Schweizerische Medizinische Wochenschrift 95: 1453.
• 15 Von Felten A, Duckert F, Frick P. G. 1966; Familial disturbance of fibrin monomer aggregation. British Journal of Haematology 12: 667.
• 16 von Felten A, Frick P. G, Straub P. W. 1969; Studies on fibrin monomer aggregation in congenital dysfibrinogenemia (Fibrinogen “Zurich”). Separation of a pathological from a normal fibrin fraction. British Journal of Haematology 16: 353.
• 17 Von Felten A, Straub P. W, Frick P. G. 1969; Dysfibrinogenemia in a patient with primary hepatoma. First observation of an acquired abnormality of fibrin monomer aggregation. New England Journal of Medicine 280: 405.
• 18 Forman W. B, Boyer M. H, Ratnoff O. D. 1967; A hereditary defect in the coagulation of fibrinogen by thrombin: studies in a family with fibrinogen Cleveland. Blood 30: 863.
• 19 Forman W. B, Ratnoff O. D, Boyer M. H. 1968; An inherited qualitative abnormality in plasma fibrinogen: Fibrinogen “Cleveland”. Journal of Laboratory and Clinical Medecine 72: 455.
• 20 Funck C, Stocker K, Straub P. W. 1970 Reptilase in diagnosis and evaluation of dysfibrinogenemias with observations in a new fibrinogen variant. Abstract of 13th International Congress of Hematology, Munich .
• 21 Funck C, Straub P. W. 1970; Hereditary abnormality of fibrin monomer aggregation (Fibrinogen Zurich II). Abstract of 4th Annual Meeting of European Society of Clinical Investigation, Scheveningen. European Journal of Clinical Investigation 01: 131.
• 22 Gaston L. W, Baue A. E, Pfaff D. A, Wise L. 1971; Spleno renal shunt, cholecystectomy and appendectomy in a patient with hemophilia A, an abnormal fibrinogen and thrombocytopenia. Annals of Surgery 173: 234.
• 23 Gralnice H. R, Givelber H. M, Finalayson J. S. 1970; A familial bleeding disorder associated with dysfibrinogenemia (Fibrinogen “Bethesda”). Clinical Research 18: 405.
• 24 Gralnice H. R, Givelber H. M, Finlays J. S. 1972. Congenital dysfibrinogenemia: fibrinogen Bethesda II. Abstract of 3rd Congress of the International Society on Thrombosis and Haemostasis . Washington D. C.: 96.
• 25 Gealmck H. R, Givelber H. M, Finlayson J. S. 1973; A new congenital abnormality of human fibrinogen: Fibrinogen Bethesda II. Thrombosis et Diathesis Haemorrhagica 29: 562.
• 26 Gralnick H. R, Givelber H. M, Shainoff J. R, Finlayson J. S. 1971; Fibrinogen “Bethesda” : a congenital dysfibrinogenemia with delayed fibrinopeptide release. Journal of Clinical Investigation 50: 1819.
• 27 Guillin M. C, ohéMena D. 1973 Fetal fibrinogen and fibrinogen Paris I: Comparative fibrin monomers aggregation studies. Thrombosis Research (in press).
• 28 Hampton J. W. 1968; Qualitative fibrinogen defect associated with abnormal fibrin stabilization. Journal of Laboratory and Clinical Medicine 72: 882.
• 29 Hampton J. W, Morton R. O. 1970; Fibrinogen “Oklahoma’⁵ . Recharacterization of a familial bleeding tendency. Proceedings of International Congress of Hematology abstract 313.
• 30 Hasselback R, Marion R. B, Thomas J. W. 1963; Congenital hypofibrinogenemia in five members of a family. Canadian Medical Association Journal 88: 19.
• 31 Imperato Di C, Dettori A. G. 1958; Ipofibrinogenemia congenita con fibr ino as tenia. Helvetica Paediatrica Acta 13: 380.
• 32 Jackson D. P, Beck E. A. 1970. Inherited abnormal fibrinogens. in Brinkhotjs K. M. (ed.). Hemophilia and New Hemorrhagic States . University of North Carolina Press; Chapel Hill: 225.
• 33 Jackson D. P, Beck E. A, Charache P. 1965; Congenital disorders of fibrinogen. Federation Proceedings 24: 816.
• 34 Jackson D. P, Charache P, Beck E. A. 1968. Inherited abnormal fibrinogens. Proceedings of the 12th Congress of the International Society of Haematology . New York: 175.
• 35 Jacobsen C. D, Hoak J. C. 1973; Fibrinogen Iowa City : an abnormal fibrinogen with no clinical symptoms. Thrombosis Research 02: 261.
• 36 Janssen C. L, Yreeken J. 1971; Fibrinogen Amsterdam : another hereditary abnormality of fibrinogen. British Journal of Haematology 20: 287.
• 37 Krause W. H, Heene D. L, Lasch H. G. 1973; Congenital dysfibrinogenenia (Fibrinogen Giessen). Thrombosis et Diathesis Haemorrhagica 29: 547.
• 38 Krause W. H, Heene D. L, Zimmermann P, Lasch H. G. 1972. Congenital dysfibrinogenemia. Abstract of 3rd Congress of the International Society on Thrombosis and Haemostasis . Washington D. C: 112.
• 39 Krause W. H, Zimmermann P. 1972; Quantitative elektronenmikroskopische Untersuchungen zur Fibrinstruktur bei Dysfibrinogenämie. Klinische Wochenschrift 50: 557.
• 40 Lacombe M, Soria J, Soria C, D’Angelo G, Lavallee R, Bonny Y. 1972. A new case of congenital dysfibrinogenemia without bleeding tendency. The fibrinogen “Montréal³⁵ . Abstract of 3rd Congress of the International Society on Thrombosis and Haemostasis . Washington D. C: 114.
• 41 Lacombe M, Soria J, Soria C, d’Angelo G, Lavallee R, Bonny Y. 1973; Fibrinogen Montreal. A new case of congenital dysfibrinogenenia with defective aggregation of monomers. Thrombosis et Diathesis Haemorrhagica 29: 536.
• 42 Mammen E. F, Prasad A. S. 1968; Familiäre Dysfibrinogenämie. Fibrinogen »Detroit«. Yerhandlungen der Deutschen Gesellschaft für innere Medizin 74: 140.
• 43 Mammen E. F, Prasad A. S, Au C. C. 1968; Studies on a family with dysfibrinogenemia. Proceedings of 16th Annual Symposium on blood . College of Medicine Wayne State University 24.
• 44 Mammen E. F, Prasad A. S, Barnhart M. I, Au C. C. 1969; Congenital dysfibrinogenemia: Fibrinogen “Detroit⁵⁵ . Journal of Clinical Investigation 48: 235.
• 45 Mammen E. F, Prasad A. S, Barnhart M. I, Au C. C. 1970. Fibrinogen “Detroit⁵⁵ . In: Brinkhous K. M. (ed.) Hemophilia and New Hemorrhagic States . University of North Carolina Press; Chapel Hill: 233.
• 46 Martinez J, Holburn R. R, Shapiro S. S, Erslev A. J. 1972; Hereditary hypodysfibrinogenemia characterized by fibrinogen hypercatabolism. Journal of Clinical Investigation, abstract 51: 62 a.
• 47 Ménaché D. 1963. Dysfibrinogénémie constitutioneile et familiale. Proceedings of 9th Congress of European Society of Haematology, Lisbon . Karger, S; Basel/New-York: 1255.
• 48 Ménaché D. 1964; Constitutional and familial abnormal fibrinogen. Transactions International Committee on Blood Clotting Factors, Gleneagles, Scotland 1963. Thrombosis et Diathesis Haemorrhagica suppl. 13, 173.
• 49 Mester L, et Szabados L. 1968; Différences constitutionnelles dans les fragments glucidiques d’un fibrinogène humain anormal. Comptes rendus de l’Académie des Sciences de Paris 266: 34.
• 50 Mester L, et Szabados L. 1970; Structure défectueuse et biosynthèse des fractions glucidiques dans les variantes pathologiques du fibrinogène. Nouvelle Revue Française d’Hématologie 05: 679.
• 51 Mester L, Szabados L, et Soria J. 1970; Les modifications de la composition glucidique du fibrinogène dans les cas de dysfibrinogénémies acquises. Comptes rendus de l’Académie des Sciences de Paris 271: 1813.
• 52 Mosesson M. W. (1970a); In Discussion. Thrombosis et Diathesis Haemorrhagica suppl. 39: 337.
• 53 Mosesson M. W. (1970b): Fibrinogen “Baltimore”. Physicochemical characterization. In: Brinkhous K. M. (ed.) Hemophilia and New Hemorrhagic States . University of North Carolina Press; Chapel Hill: 247.
• 54 Mosesson M. W, Beck E. A. 1969; Chromatographic, ultracentrifugal, and related studies on fibrinogen “Baltimore”. Journal of Clinical Investigation 48: 1656.
• 55 Samama M, Soria J, Soria C, Bousser J. 1968. Congenital and familial dysfibrinogenemia without bleeding tendency. Abstracts of simultaneous sessions of 12th Congress of the International Society of Haematology . New York: 179.
• 56 Samama M, Soria J, Soria C, et Bousser J. 1969; Dysfibrinogénémie congénitale et familiale sans tendance hémorragique. Nouvelle Revue Française d’Hématologie 09: 817.
• 57 Shainoff J. R, Beck E. A, Jackson D. P. 1970; Subfractions of fibrinogen “Baltimore” differing in content of phosphorylated fibrinopeptide. Program of 30th Annual Meeting of the American Society of Haematology . 348.
• 58 Sherman L. A, Gaston L. W, Spivak A. R. 1968; Studies on a patient with a fibrinogen variant and hemophilia A. Journal of Laboratory and Clinical Medecine 72: 1017.
• 59 Sherman L. A, Gaston L. W, Kaplan M. E, Spivack A. R. 1972; Fibrinogen “St. Louis” : a new inherited fibrinogen variant, coincidentally associated with hemophilia A. Journal of Clinical Investigation 51: 590.
• 60 Soria J, Coupier J, Samama M, Tixier P, Bilski-Pasquier G. 1968. Dysfibrinogenemia without bleeding tendency with abnormal polymerization of fibrin monomers in a case of severe hepatitis. 12th Congress of the International Society of Haematology . New York: abstract, 180.
• 61 Soria J, Samama M, Soria C, Conard J, Kling C, Poirot E, Bousser J. 1971. Two new cases of congenital dysfibrinogenemia. 2nd Congress of the International Society on Thrombosis and Haemostasis . Oslo, Norway: 58.
• 62 Soria J, Soria C, Samama M, Coupier J, Girard M. L, Bousser J, et Bilski-Pasquier G. (1970a): Dysfibrinogénémies acquises dans les atteintes hépatiques sévères. Coagulation 03: 37.
• 63 Soria J, Soria C, Samama M, Mester J, Girard M. L, et Bilski-Pasquier G. (1970b): Les dysfibrinogénémies acquises dans les atteintes hépatiques sévères. Proceedings of 13th International Congress of Haematology . abstract 313.
• 64 Soria J, Soria C, Samama M, Poirot E, Kling C. 1972; Fibrinogen “Troyes”, Fibrinogen “Metz”. Two new cases of congenital dysfibrinogenemia. Thrombosis et Diathesis Haemorrhagica 27: 619.
• 65 Soulier J. P, Prou-Wartelle O. 1967; Study of thrombin-coagulase. Thrombosis et Diathesis Haemorrhagica 17: 321.
• 66 Streiff F, Alexandre P, Vigneron C, Soria J, Soria C, Mester L. (1971a): A new case of dysfibrinogenemia: The fibrinogen “Nancy”. 2nd Congress of the International Society on Thrombosis and Haemostasis . Oslo, Norway: abstract, 60.
• 67 Streiff F, Alexandre P, Vigneron C, Soria J, Soria C, et Mester L. (1971b): Un nouveau cas d’anomalie constitutionnelle et familiale du fibrinogène sans diathèse hémorragique. Thrombosis et Diathesis Haemorrhagica 26: 565.
• 68 Verhaeghe R, Van Damme B, Molla A, Vermylen J. 1972; Dysfibrinogenaemia associated with primary hepatoma. Scandinavian Journal of Haematology 09: 451.
• 69 Verstraete M. 1970. In Discussion. Thrombosis et Diathesis Haemorrhagica. suppl. 34 334.
• 70 Winckelmann G, Augustin R, Baudilla K. 1971. Congenital dysfibrinogenemia. Report of a new family (fibrinogen “Wiesbaden”). 2nd Congress of the International Society on, Thrombosis and Haemostasis . Oslo, Norway: abstract 64.
• 71 Zietz B. H, Scott J. L. 1970; An inherited defect in fibrinogen polymerization : fibrinogen “Los Angeles”. Clinical Research 18: 179.